Institutional Analyst Inc. announced the release of the 2021 Psychedelic Investor Guide on Monday, October 18th. The Psychedelic Investor Guide is the most comprehensive and easy to use guide covering...
To appear on an upcoming episode on Psychedelic Investor TV in conjunction with New to the Street TV airing on News Max, contact Roland Rick Perry at 310-594-8062 or Roland@InstitutionalAnalyst.com...
News Channel 5 Nashville. Ketamine infusions are being used to treat patients with severe depression. The medicine is also a treatment for curb substance abuse addictions.
Pasithea Therapeutics recently raised $24 million at its initial public offering (“IPO”). The Company’s Common Stock began trading on The Nasdaq Capital Market on September 15, 2021, under the...
"I believe that we are on the verge of curing, as opposed to simply treating, certain psychiatric maladies." Dr. Jeffrey Kamlet, Chief Medical Officer of Ehave.
The KCSA Psychedelics Conference features live presentations and speakers who will address the various investment opportunities in psychedelic treatments for mental health disorders.
